Computational Nuclear Oncology Toward Precision Radiopharmaceutical Therapies: Current Tools, Techniques, and Uncharted Territories

¹Division of Radiology and Radiological Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland;
²Department of Biomedical Engineering, University of California Davis, Davis, California;
³Institute of Nuclear Medicine, Glen Burnie, Maryland;
⁴Department of Radiology, University of British Columbia, Vancouver, British Columbia, Canada;
⁵Department of Biomedical Engineering and Mallinckrodt Institute of Radiology, Washington University, St. Louis, Missouri;
⁶School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia;
⁷Department of Biomedical Engineering, University of Massachusetts, Amherst, Massachusetts;
⁸Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut;
⁹Hermes Medical Solutions, London, United Kingdom;
¹⁰Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;
¹¹Department of Radiology, Weill Cornell Medical College, New York, New York;
¹²Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York;
¹³Department of Nuclear Medicine, University of Bern, Bern, Switzerland;
¹⁴Department of Medical Physics, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy;
¹⁵Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva, Switzerland;
¹⁶Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, Netherlands;
¹⁷United Theranostics, Bethesda, Maryland; and
¹⁸Department of Physics, University of British Columbia, Vancouver, British Columbia, Canada